Preoperative immunotherapy for mesothelioma shows favorable outcomes
Researchers found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can be removed with surgery, with immunotherapy ahead of surgery resulted in favorable clinical outcomes.
Materials provided by Baylor College of Medicine. Note: Content may be edited for style and length.
Source link aaaaa